| CLYM Average Annual Return Chart Since 2021 | |||
Also see: • CLYM stock yearly return 2022 • CLYM stock yearly return 2023 • CLYM stock yearly return 2024 • CLYM stock yearly return 2025 • CLYM YTD return | |||
| Average Annual Return Benchmarks |
|
Compare CLYM average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| CLYM Share Performance |
| CLYM Average Annual Return Table Since 2021 | ||||||||||||||||||||||||||||||
CLYM average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| About Climb Bio Inc |
| Climb Bio, Inc., formerly Eliem Therapeutics, Inc., is a clinical-stage biotechnology company. Co. is focused on developing therapeutics for patients with immune-mediated diseases. Co.'s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody designed to deplete CD19-positive B cells, including antibody-secreting cells, in order to directly reduce pathogenic autoantibodies. The reduction of autoantibodies has the potential to be disease-modifying in autoantibody-driven diseases, such as systemic lupus erythematosus, immune thrombocytopenia, and membranous nephropathy. The budoprutug is in Phase I clinical trial. The CLYM average annual return since 2021 is shown above.
The Average Annual Return on the CLYM average annual return since 2021 page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends. Thus, researching Average Annual Returns is good practice for investors — whether CLYM average annual return since 2021 or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CLYM average annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| CLYM Current Stock Quote |
 Free CLYM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in Average Annual Return! | |
|
| Average Annual Return Peers |
| Climb Bio (CLYM) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
CMPX Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!